Short answer · Medically reviewed summary · Last updated: 2023-07-13
Paraneoplastic Neurologic Syndromes (PNS) are rare disorders that occur in association with cancer. They are caused by an abnormal immune response triggered by the presence of a tumor in the body.
18
What is the prevalence of Paraneoplastic Neurologic Syndromes?
Prevalence of Paraneoplastic Neurologic Syndromes: how many people are affected worldwide, differences by sex and region, with sources.
Paraneoplastic Neurologic Syndromes (PNS) are rare disorders that occur in association with cancer. They are caused by an abnormal immune response triggered by the presence of a tumor in the body. PNS can affect various parts of the nervous system, including the brain, spinal cord, and peripheral nerves.
The prevalence of PNS varies depending on the specific syndrome and the type of cancer involved. Overall, PNS are considered to be rare conditions, with an estimated prevalence ranging from 0.01% to 0.1% in the general population. However, the prevalence may be higher in individuals with certain types of cancer, such as small cell lung cancer or ovarian cancer.
It is important to note that PNS can be challenging to diagnose due to their rarity and the wide range of symptoms they can present. Additionally, the prognosis for PNS can vary depending on the specific syndrome and the underlying cancer. Early recognition and treatment of PNS are crucial for improving outcomes and managing symptoms.
In conclusion, Paraneoplastic Neurologic Syndromes are rare disorders associated with cancer, with a prevalence ranging from 0.01% to 0.1% in the general population.
Author: DiseaseMaps Editorial Team
Reviewed against authoritative medical sources (NIH GARD, Orphanet, OMIM)
Last updated: 2023-07-13
Medical disclaimer:
This information does not substitute professional medical advice. Always consult your doctor before making health decisions.
Source:
DiseaseMaps.org
